Medo AI Review 2026: The Smartphone-Sized Ultrasound AI Now Living Inside Exo's Handheld Probes

If you've Googled "Medo AI" expecting to find a standalone subscription, here's the first thing you should know: as of mid-2022, Medo AI was acquired by Exo, the handheld ultrasound device maker, and its core technology now ships as the AI layer inside Exo's iQ probes and Exo Works workflow platform. The original mission — using AI to make medical imaging "as easy as snapping a smartphone photo" — survived intact; the path to buying it has changed. This review explains what Medo AI's technology actually does in 2026, how it's now packaged and priced through Exo, and which alternative AI ultrasound platforms make sense if you specifically wanted standalone Medo.

Stop overpaying for AI tools! Install the PageCoupon Extension to auto-apply a 30% discount at checkout.

For verified pricing and quality comparison: https://pagecoupon.com/ai-software/medo-ai/

What Is Medo AI?

Medo AI was a Canadian (Edmonton-based) AI medical imaging company founded in 2018 that focused on automating the interpretation of ultrasound scans for non-specialist clinicians. Its core product line — most prominently MEDO-Hip and MEDO-Thyroid — used AI to guide image acquisition and produce automated diagnostic outputs from sweep-style ultrasound scans, even when the operator wasn't a sonographer.

• MEDO-Hip — Automated paediatric DDH (developmental dysplasia of the hip) screening from a 3D sweep scan
• MEDO-Thyroid — Thyroid nodule classification and risk-stratification (TI-RADS-aligned) from standard 2D ultrasound
• AI-guided image acquisition — Coaches non-sonographer clinicians through correct probe angles and sweeps
• Automated measurements — Reduces inter-operator variability that plagues hand-measured ultrasound
• Reporting integration — Exports structured findings into clinical reports
• Now bundled into Exo iQ probe firmware — The acquired tech runs natively on Exo's handheld ultrasound hardware
• Exo Works workflow layer — Cloud workflow + worklist tooling that surrounds the AI outputs
• FDA-cleared modules — Multiple modules carry US regulatory clearances (verify per use case)
• Point-of-care focus — Designed for ED, primary care, paediatrics rather than imaging-centre radiology
• Cross-platform legacy — Earlier Medo modules ran on third-party probes; new development is Exo-first

The Underrated Use Case: Paediatric Hip Screening Without A Sonographer

The single most defensible workflow Medo AI ever built — and the one Exo continues to push — is MEDO-Hip for paediatric DDH screening. Standard hip ultrasound for infants requires a trained sonographer, costs $200–$500 per scan, and is heavily booked in many health systems. MEDO-Hip lets a paediatrician or nurse perform a 30-second 3D sweep with a handheld probe and get an automated Graf-style classification in under a minute. This is the kind of "expand-the-workforce" application that AI imaging marketing always promises and rarely delivers — Medo's hip module actually does, which is a large part of why Exo bought them. If you're a paediatric clinic evaluating point-of-care ultrasound, this is the use case to anchor on.

Pricing & Plans (2026)

Pricing verified May 2026 against Exo's acquisition announcement (July 2022), CB Insights' company profile, and Exo's current website. Exo does not publish public list pricing; expect handheld ultrasound + AI workflow bundles to fall in the $5,000–$15,000 hardware range with annual software/support contracts on top.

Is Medo AI Pricing Worth It?

Because Medo AI is no longer a standalone SaaS, the relevant ROI math is hardware-plus-AI versus traditional ultrasound capital equipment. A traditional cart-based MSK or paediatric ultrasound system runs $9,000–$25,000 plus the cost of a credentialed sonographer, while Exo's handheld bundles cost a fraction and let mid-level clinicians acquire usable images. For point-of-care use cases — paediatric hip screening, thyroid follow-up, ED FAST exams — the math heavily favours the Exo+Medo bundle. For dedicated radiology departments, traditional cart-based systems still win on image quality.

Is There A Medo AI Coupon Code In May 2026?

There is no public coupon code for Medo AI in May 2026, and there cannot meaningfully be one — the product is now sold as enterprise medical imaging hardware via Exo's direct sales team, not as self-checkout SaaS. The realistic discount paths are (1) volume bundles for multi-site health systems, (2) trade-in credits against existing ultrasound capital equipment, and (3) academic-institution pricing. No public, officially-sanctioned coupon was found as of May 2026.

Pros & Cons

Pros:

• Genuine point-of-care expansion — MEDO-Hip and MEDO-Thyroid let non-specialists produce diagnostic-quality output that previously required sonographers
• FDA-cleared core modules — Regulatory standing is real, not pre-clearance experimental software
• Tight hardware/software integration via Exo — Eliminates the "AI floating on top of someone else's probe" coordination problem
• Strong paediatric DDH evidence base — One of the clearer published case studies for AI-guided ultrasound replacing sonographer time
• Workforce-multiplier framing — Useful in regions with sonographer shortages, especially community paediatrics

Cons:

• Standalone purchase is no longer possible — If you wanted Medo AI as a software-only license on your existing equipment, that route effectively closed in 2022
• Pricing opacity — Custom enterprise pricing means you cannot self-serve evaluate cost vs alternatives without a sales call
• Narrower module library than competitors — Aidoc, Qure.ai, and others cover a wider range of imaging modalities than Medo's two flagship modules
• Hardware dependency — Practically locked into Exo's iQ hardware roadmap going forward
• Limited public reviewer presence — As an enterprise medical imaging tool, there's relatively little G2/Reddit/Trustpilot signal vs consumer SaaS

Best Alternatives

1. Exo iQ + Exo Works — The actual successor product if you want what Medo AI now is; pick this if you're a point-of-care customer.
2. Butterfly iQ3 — The other major handheld ultrasound platform with its own AI roadmap; pick this if you prefer a different hardware ecosystem with broader module coverage.
3. Caption Health (Caption Care) — Specialised in echocardiography AI guidance; pick this if cardiology imaging is the priority.
4. Aidoc — Imaging AI for cross-modality radiology workflow; pick this if you're a radiology department, not a point-of-care clinic.
5. Qure.ai — Strong chest X-ray and CT AI; pick this if you need imaging AI outside ultrasound entirely.
6. Nanox.AI — Population-health imaging AI focused on opportunistic findings; pick this for screening programs at scale.

The Final Verdict

Medo AI was — and through Exo, still is — one of the most genuinely useful applications of AI in point-of-care imaging, particularly for paediatric hip screening and thyroid nodule risk-stratification. The complication is that the product no longer exists as a standalone purchase: since Exo's July 2022 acquisition, the AI is embedded in Exo's iQ handheld ultrasound platform and sold as enterprise medical hardware. If that's what you wanted, the path is straightforward; if you specifically wanted a software-only license on your existing imaging hardware, you'll need to evaluate alternatives. As an independent reviewer who's tracked imaging AI for several years, the Medo+Exo combination earns a recommendation for paediatric clinics, primary care groups, and EDs adopting point-of-care ultrasound, and a "this isn't the right shape" caveat for radiology departments running cart-based systems.

Rating: 3.8/5

Get started with Medo AI here: https://pagecoupon.com/ai-software/medo-ai/

← Back to all posts